- Poster presentation
- Open Access
Potent inhibition of nitroglycerin bioactivation by diphenyleneiodonium (DIP)
BMC Pharmacology and Toxicology volume 14, Article number: P49 (2013)
Aldehyde dehydrogenase-2 (ALDH2) catalyzes vascular bioactivation of the antianginal drug nitroglycerin (GTN) to yield nitric oxide (NO) or a related species that activates soluble guanylate cyclase (sGC), resulting in cGMP-mediated vasodilation . Accordingly, established ALDH2 inhibitors attenuate GTN-induced vasorelaxation in vitro and in vivo. However, the ALDH2 hypothesis has not been reconciled with early studies demonstrating potent inhibition of the GTN response by diphenyleneiodonium (DPI) , a widely used inhibitor of flavoproteins, in particular NADPH oxidases. We addressed this issue and investigated the effects of DPI on GTN-induced relaxation of rat aortic rings and the function of purified ALDH2.
DPI (0.3 µM) inhibited the high affinity component of aortic relaxation to GTN without affecting the response to NO, indicating that the drug interfered with GTN bioactivation. As shown in Figure 1A, DPI inhibited bioactivation of GTN (1 µM) by ALDH2, assayed as activation of purified sGC, with an IC50 of 0.20±0.03 µM, whereas cGMP formation induced by the NO donor DEA/NO was not affected. DPI (10 µM) caused a pronounced right-ward shift of the GTN concentration response (Figure 1B), indicating that the drug acts in a GTN-competitive manner. The effect on GTN bioactivation was accompanied by GTN-competitive inhibition of 1,2-glycerol dinitrate formation (IC50 0.21±0.04 µM in the presence of 2 µM GTN). DPI also inhibited the established dehydrogenase and esterase activities of ALDH2 with similar potency, again in a substrate-competitive manner. This was confirmed by molecular modeling, suggesting overlapping binding sites of DPI and GTN in the catalytic site of the enzyme (Figure 2). In contrast to ALDH2, ALDH1 and alcohol dehydrogenase were only partially (ALDH1) or not at all (ADH) inhibited by up to 0.1 mM DPI.
The identification of DPI as potent ALDH2 inhibitor may have implications beyond the cardiovascular pharmacology of organic nitrates. A well established function of ALDH2 is detoxification of reactive aldehydes in liver and heart. NADPH oxidase activation has been implicated in both alcohol-induced liver injury and cardiac dysfunction. In view of the present results, showing that DPI potently inhibits the various enzymatic functions of ALDH2, it may be necessary to revise some of the earlier conclusions that are based on inhibitory effects of aryliodonium compounds.
Mayer B, Beretta M: The enigma of nitroglycerin bioactivation and nitrate tolerance: News, views, and troubles. Br J Pharmacol. 2008, 155: 170-184.
McGuire JJ, Anderson DJ, Bennett BM: Inhibition of the biotransformation and pharmacological actions of glyceryl trinitrate by the flavoprotein inhibitor, diphenyleneiodonium sulfate. J Pharmacol Exp Ther. 1994, 271: 708-714.
About this article
Cite this article
Neubauer, R., Neubauer, A., Wölkart, G. et al. Potent inhibition of nitroglycerin bioactivation by diphenyleneiodonium (DIP). BMC Pharmacol Toxicol 14, P49 (2013). https://0-doi-org.brum.beds.ac.uk/10.1186/2050-6511-14-S1-P49
- Nitric Oxide
- NADPH Oxidase
- Guanylate Cyclase
- Aortic Ring